Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle.
Cha
Yong-Mei
YM
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA.
Redfield
Margaret M
MM
Shen
Win-Kuang
WK
Gersh
Bernard J
BJ
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D020517:Atrial Appendage; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D019090:Case Management; D015331:Cohort Studies; D004554:Electric Countershock; D005260:Female; D006331:Heart Diseases / Q000209:etiology; D006333:Heart Failure / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000503:physiopathology; D008297:Male; D015995:Prevalence; D011379:Prognosis; D013318:Stroke Volume; D017180:Tachycardia, Ventricular / Q000209:etiology* / Q000503:physiopathology; D013927:Thrombosis / Q000209:etiology; D018487:Ventricular Dysfunction, Left / Q000209:etiology* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents